On a gray morning in Sacramento, parents still argue in clinic waiting rooms about shots, school forms, and whom to trust with a child’s health. That argument followed Richard Pan from the pediatric exam room into the state Senate, and it now follows him toward Congress, where the fights over Medicaid, insurance costs, and federal vaccine policy have only grown louder. He arrives not as a newcomer to controversy but as the lawmaker most closely tied to California’s strict school immunization rules, and as a doctor who says the next battles will be fought over who can still afford care.
A physician who learned politics in the exam room

Pan trained as a pediatrician and spent years treating children whose families navigated crowded clinics, incomplete records, and illnesses that vaccines had already made rare in much of the country. Colleagues describe a clinician who talks about policy the way he talks about a chart: what is the risk, who bears it, and what happens if the system fails the patient in front of him. That habit shaped a legislative career built less on slogans than on statutes. In Sacramento he became the public face of bills that tightened vaccination requirements for school entry and limited the exemptions that had allowed clusters of unvaccinated children to grow.
Supporters say the work was a direct response to measles outbreaks and to physicians who, in their view, signed medical exemptions too freely. Opponents say the state substituted mandate for persuasion and treated hesitant parents as a problem to be managed rather than heard. Both descriptions stick to him. He does not apologize for the choice. He argues that a classroom is a shared space, and that the freedom to skip a shot is not free for the infant too young to be immunized or the child whose immune system cannot mount a response.
The California laws that made his name

The measure known as Senate Bill 277, enacted in 2015, ended the personal belief exemption for required school vaccines in California. A later bill tightened rules around medical exemptions after officials and reporters documented patterns of questionable waivers. Together the laws made California one of the strictest states in the nation on school immunization. Vaccination rates for kindergarten entry rose. Outbreaks did not vanish, but public health officials credited the statutes with closing a loophole that had concentrated risk in particular schools and communities.
The political cost was real. Hearings drew long lines of angry parents. Pan received threats. Town halls turned raw. He kept returning to the same claim: the science on routine childhood vaccines is among the most studied bodies of evidence in medicine, and state law should reflect that record rather than a patchwork of online rumor. Critics answered that certainty from government is itself a reason for distrust, especially among families who feel dismissed by institutions. That tension did not resolve in Sacramento. It simply moved, with him, onto a larger stage.
Why Congress is a different kind of clinic

A state senator can write a school rule. A member of Congress inherits a federal budget, a health agency in turmoil, and a public argument that no longer stays inside state lines. Pan’s stated agenda, as described by allies and by his own campaign materials, centers on three tasks: restoring Medicaid funding that low income families rely on, reviving subsidies that keep marketplace insurance within reach, and challenging vaccine positions associated with Robert F. Kennedy Jr. and with a broader turn toward skepticism inside federal health leadership.
Those goals are linked in his telling. A child who loses Medicaid does not only lose a card. The family may delay visits, skip prescriptions, and fall out of the schedule that keeps vaccines, screenings, and asthma care on track. A household that cannot afford a marketplace plan may do the same. Pan frames coverage as the plumbing of public health. Without it, he says, even the best scientific guidance reaches fewer people.
Medicaid and the families who would feel a cut

Medicaid, including the children’s coverage known as CHIP in many states, insures a large share of American kids and a crucial share of births, nursing home stays, and disability care. When Congress debates work rules, provider taxes, or across the board reductions, the language sounds technical. The effects are not. Clinics in rural counties and urban neighborhoods alike depend on those payments to keep doors open. Pediatric practices with thin margins cannot absorb a sudden drop and still offer evening hours, interpreters, and vaccine stock.
Pan’s pitch to colleagues is that cuts sold as fiscal discipline often shift costs onto emergency rooms and onto counties. He wants restorations where recent federal actions have squeezed eligibility or provider rates, and he wants the debate anchored in what happens to a child with diabetes or a premature infant when the nearest specialist stops taking the program. Opponents of expansion argue that states should carry more of the bill and that open ended federal matching rewards spending. He does not deny the budget pressure. He denies that children are the right place to find the savings.
Insurance subsidies and the price of staying covered

The enhanced premium subsidies that lowered marketplace costs for millions of people were always politically fragile. When they shrink or expire, notices arrive in mailboxes: higher premiums, narrower networks, a quiet decision by some households to go uninsured for a year and hope. Pan treats that decision as a public failure, not a private preference. He wants the subsidies revived and made stable enough that families can plan, rather than relearn the rules every election cycle.
Here his physician’s instinct and his legislator’s instinct meet. Uninsured adults delay cancer screening. Uninsured parents skip their own care and sometimes their children’s. Hospitals then absorb uncompensated treatment and pass pieces of that burden into everyone else’s bill. Restoring subsidies, in this view, is not a gift to insurers. It is a way to keep people inside a system that can actually prevent the expensive crisis. Skeptics will ask what the ten year cost is, and he will have to answer with numbers as well as stories. A Congress that has grown allergic to open ended health spending will not be moved by biography alone.
The fight over vaccines moves to Washington

California could set school rules. It cannot set the tone of the Centers for Disease Control and Prevention, the makeup of federal advisory committees, or the messages that cabinet officials send about routine immunization. Pan has been blunt that he intends to contest policies and rhetoric he believes undermine confidence in vaccines without offering a safer alternative. He names Kennedy’s long record of vaccine criticism as a central concern, not a side issue.
The disagreement is not only about one appointee. It is about whether federal health agencies will keep recommending the childhood schedule on the basis of large safety studies, or whether those recommendations will be reopened in ways that signal doubt even when the evidence has not changed. Pan’s allies in medicine fear a slow erosion: fewer kids completing the schedule, more measles in pockets of low coverage, more time spent by clinicians rebutting claims that were answered years ago. His critics say dissent belongs in a democracy, and that a doctor turned lawmaker should not treat questions as heresy.
He is likely to answer with process as much as passion. Oversight hearings, budget language, and public letters do not rewrite a parent’s mind overnight. They do shape what agencies are allowed to say, which data they must publish, and whether advisory seats go to specialists or to activists. That is the narrow lane Congress actually controls. Pan knows it. He also knows that lane is where national arguments get ratified.
Trust, listening, and the limits of a statute

Even supporters of strict school laws concede a harder truth. Mandates can raise rates. They cannot, by themselves, repair trust. Communities that felt coerced in 2015 did not all become confident in 2016. Some parents complied and stayed angry. Others left public school, sought doctors willing to stretch a medical exemption, or moved. A member of Congress who wants higher vaccination coverage in 2027 will need more than the memory of a successful state bill.
Pan’s record suggests he understands the clinical half of that work better than many politicians. Pediatricians who persuade rather than lecture spend time on specific fears: a cousin’s story, a badly explained side effect, a schedule that feels crowded. Federal policy can fund that time. It can pay for community health workers, for translated materials that are not condescending, and for clinics that do not turn a vaccine visit into a bill a family cannot face. It can also stop officials from amplifying claims that the evidence does not support. Those are different tools from a school exclusion rule, and they may matter more in states that will never copy California.
What colleagues expect and what critics fear

Democrats who backed his state bills expect a reliable vote for coverage expansions and a fluent spokesperson when vaccine hearings turn theatrical. Republicans and some libertarian leaning Democrats expect a foil, a symbol of coastal mandate politics dropped into a national debate already raw from the pandemic years. Pan will be asked, again and again, whether he respects parental authority. His answer has been consistent: parents decide a great deal, and the state still has a duty when one family’s choice changes the risk for someone else’s child.
There is a practical test beyond the hearing room. Can he write amendments that survive a closely divided chamber, or only deliver speeches that rally people who already agree? Restoring Medicaid dollars and subsidy levels requires coalitions, scorekeeping, and compromises that a state supermajority did not demand. If he treats every negotiation as a betrayal of the exam room, he will lose. If he treats every compromise as success, the families who sent him will notice. That is the ordinary dilemma of a legislator, made sharper because his brand is moral clarity on shots and coverage.
The voters behind the agenda

The people who would feel his agenda first are not abstract. They are parents renewing marketplace plans, grandparents in nursing facilities paid for by Medicaid, and pediatricians trying to keep vaccine refrigerators stocked while reimbursement wobbles. They are also the parents who still believe the California laws went too far and who will watch any federal vaccine fight for signs of the same approach. A honest politics has to speak to both groups without pretending they want the same thing.
Pan’s advantage is fluency. He can explain a deductible and a contraindication in the same conversation. His risk is that fluency sounds, to skeptics, like certainty imposed from above. The country is full of people who felt talked down to during the pandemic and who have not forgiven the tone, even when they accepted the shot. A congressman who wants their trust will have to show that he can distinguish a real safety signal from a rumor, and that he will say so in public when the data demand it. Credibility is not a press release. It is a habit.
What success would look like

Success, on the terms he has set, would be measurable and incomplete. Medicaid funding restored where it was cut, so that pediatric visits and long term care do not become the shock absorbers of a budget deal. Subsidies revived so that a family just above the poverty line is not priced out of a plan. Oversight that keeps federal vaccine recommendations tied to published evidence, and that refuses to launder debunked claims through the authority of a government seal.
None of that ends the argument in waiting rooms. Parents will still ask hard questions. Some will still refuse. A democracy can live with refusal better than it can live with epidemics born of confusion, or with a health system that works only for people who can pay. Pan built his reputation by choosing the stricter rule in California. In Congress he will be judged by whether he can protect coverage and scientific standards without mistaking a gavel for a stethoscope, and without forgetting that the patient is still a person, not a voting bloc.
A larger test for public health

The larger test is not one member’s committee assignments. It is whether the United States can keep the basic agreements that made routine immunization and broad coverage possible: agencies that publish their evidence, laws that do not abandon children to the cheapest cut, and leaders willing to argue in plain language. Richard Pan is betting that a pediatrician’s record in a contentious state is preparation for that test. Voters and colleagues will decide whether the bet holds, one hearing and one budget line at a time.